UnitedHealth Group generated strong financial results during the third quarter as its subsidiary firm Optum continued to find success.

UnitedHealth Group reported upbeat earnings for Q3, beating consensus. But analysts concerned about higher costs.

UnitedHealth's Q3 earnings reveal rising costs and Medicare Advantage headwinds. See more on how these factors are affecting ...

UnitedHealth Group's stock fell 8.1% despite beating Q3 estimates due to conservative 2024 and 2025 EPS guidance. Find out ...

Quarterly profit of $6.06 billion at the Minnetonka-based company beat analyst estimates on a per-share basis as revenue grew ...

Adjusted Earnings Outlook for 2024: Narrowed to a range of $27.50 to $27.75 per share. UnitedHealth Group Inc (NYSE ... Q: ...

Health-care companies fell after an earnings warning from the largest health insurer by enrollees.

Wall Street stocks were in the red at the close of trading on Tuesday as Q3 earnings season kicked up a gear. At the close, ...

UnitedHealth Group kicked off another round of earnings calls for major health insurance companies on Tuesday morning, where ...

Erin Wright, an analyst from Morgan Stanley, maintained the Buy rating on UnitedHealth (UNH – Research Report). The associated price ...

UnitedHealth Group reported increased revenue, but also noted some cyberattack challenges that ended up affecting full-year ...

UNH's third-quarter earnings benefit on the back of client wins in the Optum Rx sub-unit, partly offset by an elevated ...